Post laparascopy shoulder pain

Premediacation with single dose of Acetazolamid for the control of referred shoulder pain after laparoscopic cholecystectomy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201407111772N15

Enrollment

Registered

2014-07-19

Start date

2013-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post laparascopy shoulder pain. Carbonic-anhydrase inhibitors

Interventions

Acetazolamide 5mg/kg one hour before surgery

Acetazolamide 5mg/kg one hour before surgery.

Treatment - Drugs

Eligibility

Sex/Gender

All

Age

30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: all patients undergoing laparoscopic cholecystectomy in rang of 30-60 years old. Exclusion criteria:1- addiction 2-psychopathic patients 3- patient avoidance 4-previous pain full disease 5-Sensitivity to sulfonamides 6- renal failer 7-COPD and lung disease8-pregnancy 9-hematologic disorder 10- previous acidosis 11- renal implantation 12-exitance of electrolyte imbalance 13- previous Lithium consumption 14- CNS disorder 15-Hepatic disorder16-use of other diuretics 17-previous shoulder pathology 18- previous muscle disease 19- hypoglycemia

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: 0, 2, 4, 6, 12 and 24 hours after operation. Method of measurement: Visual Analogue Scale.	—

Secondary

Measure	Time frame
Opioid cosumption. Timepoint: 0, 2, 4, 6, 12 and 24 hours after operation. Method of measurement: Total Dose.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDawood Aghamohammadi

Tabriz university of medical science/fuculty of medicin/ Anesthesiology Dept

aghamohammadid@tbzmed.ac.ir+98 41 1381 8940

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026